Anthony G. Quinn
President and Chief Executive Officer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2016-01-01–2022-08-23
-
Start not stated–2022-08-24
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Spyre Therapeutics, Inc. (SYRE) | M.B Ch.B, Ph.D. Former President and Chief Executive Officer | $424,429 | $2,392,254 |
| 2021 | Spyre Therapeutics, Inc. (SYRE) | M.B Ch.B, Ph.D. Former President and Chief Executive Officer | $560,000 | $2,623,186 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.